Daihan Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 19, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	180,516	154,056	163,170	183,600	172,200	197,700
Market Cap Growth	17.85%	-5.59%	-11.13%	6.62%	-12.90%	4.11%
Enterprise Value	94,315	80,167	60,093	96,028	117,564	155,174
Last Close Price	30700.00	25333.88	25919.62	27814.69	25531.67	28903.95
PE Ratio	5.72	4.56	5.74	7.36	7.60	11.38
PS Ratio	0.86	0.75	0.83	1.00	1.00	1.19
PB Ratio	0.62	0.56	0.66	0.82	0.85	1.09
P/TBV Ratio	0.62	0.56	0.66	0.82	0.85	1.09
P/FCF Ratio	42.91	7.76	9.28	9.01	5.99	6.99
P/OCF Ratio	5.57	4.32	4.20	6.33	4.24	5.88
EV/Sales Ratio	0.45	0.39	0.31	0.52	0.69	0.93
EV/EBITDA Ratio	2.12	1.77	1.35	2.28	2.90	3.76
EV/EBIT Ratio	2.59	2.11	1.68	2.91	4.04	5.18
EV/FCF Ratio	22.42	4.04	3.42	4.71	4.09	5.49
Debt / Equity Ratio	0	0	-	0.03	0.12	0.16
Debt / EBITDA Ratio	0.00	0.00	-	0.15	0.58	0.70
Debt / FCF Ratio	0.01	0.00	-	0.32	0.82	1.02
Net Debt / Equity Ratio	-0.29	-0.28	-0.42	-0.40	-0.36	-0.21
Net Debt / EBITDA Ratio	-1.94	-1.70	-2.35	-2.16	-1.80	-0.94
Net Debt / FCF Ratio	-20.49	-3.89	-5.94	-4.47	-2.53	-1.37
Asset Turnover	0.64	0.66	0.69	0.67	0.65	0.66
Inventory Turnover	4.68	5.36	5.38	5.46	5.22	5.03
Quick Ratio	2.76	2.58	3.28	3.04	2.72	2.47
Current Ratio	3.55	3.22	3.87	3.65	3.20	3.10
Return on Equity (ROE)	11.24%	12.89%	12.01%	11.66%	11.79%	9.97%
Return on Assets (ROA)	6.91%	7.69%	7.83%	7.50%	6.91%	7.49%
Return on Invested Capital (ROIC)	14.76%	17.74%	19.93%	18.62%	15.86%	16.06%
Return on Capital Employed (ROCE)	12.10%	13.50%	14.20%	14.10%	12.80%	14.00%
Earnings Yield	17.48%	21.91%	17.42%	13.59%	13.16%	8.79%
FCF Yield	2.33%	12.88%	10.77%	11.10%	16.71%	14.30%
Payout Ratio	16.46%	12.82%	13.20%	8.45%	9.30%	12.13%
Buyback Yield / Dilution	-	-	1.75%	0.25%	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.